Diversity and inclusion in clinical trials
Diversity in clinical trials is important to advancing health equity and evaluating if an investigational medicine works for different groups of people and reflects the patient population likely to get treated with this medicine, if approved, regardless of their ethnicity, gender, socioeconomic status, age, ability and so forth. Still, many clinical trials lack enough participants or diversity. Many underrepresented communities may not even know they are underrepresented in research.
We at BioNTech set up clinical trial sites around the world and encourage people of all backgrounds to explore participation opportunities.